Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients

Paul D.P. Pharoah; Jean Abraham; Carlos Caldas

doi:10.1093/jnci/djs312

Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients

Paul D.P. Pharoah^*
, Jean Abraham
, Carlos Caldas

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

34 Scopus citations

Original language	English
Pages (from-to)	1263-1264
Number of pages	2
Journal	Journal of the National Cancer Institute
Volume	104
Issue number	16
DOIs	https://doi.org/10.1093/jnci/djs312
State	Published - Aug 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/jnci/djs312

Cite this

Pharoah, P. D. P., Abraham, J., & Caldas, C. (2012). Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients. Journal of the National Cancer Institute, 104(16), 1263-1264. https://doi.org/10.1093/jnci/djs312

Pharoah, Paul D.P. ; Abraham, Jean ; Caldas, Carlos. / Re : CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients. In: Journal of the National Cancer Institute. 2012 ; Vol. 104, No. 16. pp. 1263-1264.

@article{dbe9ca6106724186a3ba4b2105a1a9d3,

title = "Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients",

author = "Pharoah, \{Paul D.P.\} and Jean Abraham and Carlos Caldas",

year = "2012",

month = aug,

doi = "10.1093/jnci/djs312",

language = "אנגלית",

volume = "104",

pages = "1263--1264",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "16",

}

Pharoah, PDP, Abraham, J & Caldas, C 2012, 'Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients', Journal of the National Cancer Institute, vol. 104, no. 16, pp. 1263-1264. https://doi.org/10.1093/jnci/djs312

Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients. / Pharoah, Paul D.P.; Abraham, Jean; Caldas, Carlos.
In: Journal of the National Cancer Institute, Vol. 104, No. 16, 08.2012, p. 1263-1264.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Re

T2 - CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients

AU - Pharoah, Paul D.P.

AU - Abraham, Jean

AU - Caldas, Carlos

PY - 2012/8

Y1 - 2012/8

UR - https://www.scopus.com/pages/publications/84865515605

U2 - 10.1093/jnci/djs312

DO - 10.1093/jnci/djs312

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 22851268

AN - SCOPUS:84865515605

SN - 0027-8874

VL - 104

SP - 1263

EP - 1264

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 16

ER -

Pharoah PDP, Abraham J, Caldas C. Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients. Journal of the National Cancer Institute. 2012 Aug;104(16):1263-1264. doi: 10.1093/jnci/djs312

Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients

UN SDGs

Access to Document

Other files and links

Cite this